Ann: Appendix 4C - quarterly, page-19

That the company has systematically overcome the issues and that the company has demonstrated the ability to keep focused on the task at hand , which is the successful completion and accurate documentation of the Phase II trials. LCT are also aware that the International Medical fraternity as well as potential future customers are also monitoring LCT progress.
From my own personal perspective , I can only imagine the scrutiny that these trial results will undergo on a Global Scale..."This treatment will halt the progress of Parkinsons",,,it's a big claim, that will be examined from a multitude of other companies in the same field as well as medical practitioners and potential Licensed Stem Cell Clinics.